Benedetti & Gucer, Inc. Merck & Co., Inc. Transaction History

Benedetti & Gucer, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $54,097 - $58,870	540 Added 12.49%	4,864 $530,000
Q3 2023 Nov 02, 2023	BUY	$102.95 - $114.33 $12,559 - $13,948	122 Added 2.9%	4,324 $445,000
Q2 2023 Jul 20, 2023	BUY	$108.61 - $118.38 $88,517 - $96,479	815 Added 24.06%	4,202 $485,000
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $348,657 - $389,030	3,387 New	3,387 $360,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Benedetti & Gucer, Inc., based on Form 13F filings with the SEC.

Stay updated on Benedetti & Gucer, Inc. with notifications on news.